Results 11 to 20 of about 21,046 (202)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Cardiology Research and Practice, 2020
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery.
Dai-Min Zhang, Shaoliang Chen
doaj   +1 more source

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

Pakistan Armed Forces Medical Journal, 2020
Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study.
Waseem Raja, Naseer Ahmed Samore, Mohsin Saif, Javeria Kamran, Sidra Waheed, Naeem Tariq, Farhan Tuyyab, Abdul Hameed Siddiqui   +7 more
doaj   +1 more source

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases

Scientific Reports, 2021
This study investigated factors affecting the safety and in-stent restenosis after intracranial stent angioplasty using the Enterprise stent for symptomatic intracranial atherosclerotic stenosis.
Kun Zhang, Tian-Xiao Li, Zi-Liang Wang, Bu-Lang Gao, Jian-Jun Gu, Hui-Li Gao, Yong-Feng Wang, Jin-Chao Xia   +7 more
doaj   +1 more source

High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris

BMC Cardiovascular Disorders, 2019
Background In-stent restenosis remains an unresolved issue. Inflammation plays a pivotal role in the process of in-stent restenosis. Significant and positive associations were found between red blood cell distribution width (RDW) and inflammation.
Ning Geng, Guangsheng Su, Shaojun Wang, Deling Zou, Wenyue Pang, Yingxian Sun   +5 more
doaj   +1 more source

Viabahn for femoropopliteal in-stent restenosis

Annals of Saudi Medicine, 2012
BACKGROUND AND OBJECTIVES: In-stent restenosis in the femoropopliteal artery is common (20%-40%). Treatment of in-stent restenosis is challenged by poor patency rate.
Owayed Al Shammeri, Fahad Bitar, Jaime Ghitelman, Peter A. Soukas   +3 more
doaj   +1 more source

Paclitaxel eluting stents versus bare metal stents restenosis

Revista Cubana de Medicina Militar, 2021
Introduction: The restenosis of the paclitaxel-eluting stents used in Cuba has not been studied. Objective: To evaluate the restenosis of paclitaxel-eluting stents and conventional stents.
Ronald Aroche Aportela, Adrian Naranjo-Dominguez, Ángel Yaniel Rodríguez Navarro, Alexander Candeaux Martínez, Yaniet Miguel Vázquez, Ángel Gaspar Obregón Santos   +5 more
doaj  

In-stent restenosis

The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym, Asha, Ahmad, Bystrom, Philip V, Weiss, Robert, Jacobs, Chad E, Schwartz, Lewis B   +5 more
  +7 more sources

Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis

The Egyptian Heart Journal, 2012
Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry, Islam El-Sherbieny, Enas Swelam   +2 more
doaj   +1 more source

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST)

Revista Colombiana de Cardiología, 2012
los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los stents convencionales y ...
Jorge A. Arroyave C., MD, Magda C. Cepeda G., MD   +1 more
doaj   +1 more source

Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis. [PDF]

PLoS ONE, 2016
Carotid artery stenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy (CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and ...
Marine Gaudry, Jean-Michel Bartoli, Laurence Bal, Roch Giorgi, Mariangela De Masi, Pierre-Edouard Magnan, Philippe Piquet   +6 more
doaj   +1 more source